{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:48:17Z","timestamp":1790776097264,"version":"4.1.0"},"reference-count":110,"publisher":"Bentham Science Publishers Ltd.","issue":"16","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1D1A1B07040941"],"award-info":[{"award-number":["NRF-2018R1D1A1B07040941"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,8,26]]},"abstract":"<jats:sec><jats:title\/><jats:p>Vectors are living organisms that transmit infectious diseases from an infected animal to humans or another animal. Biological vectors such as mosquitoes, ticks, and sand flies carry pathogens that multiply within their bodies prior to delivery to a new host. The increased prevalence of Vector-Borne Diseases (VBDs) such as Aedes-borne dengue, Chikungunya (CHIKV), Zika (ZIKV), malaria, Tick-Borne Disease (TBD), and scrub typhus has a huge impact on the health of both humans and livestock worldwide. In particular, zoonotic diseases transmitted by mosquitoes and ticks place a considerable burden on public health. Vaccines, drugs, and vector control methods have been developed to prevent and treat VBDs and have prevented millions of deaths. However, development of such strategies is falling behind the rapid emergence of VBDs. Therefore, a comprehensive approach to fighting VBDs must be considered immediately. In this review, I focus on the challenges posed by emerging outbreaks of VBDs and discuss available drugs and vaccines designed to overcome this burden. Research into promising drugs needs to be upgraded and fast-tracked, and novel drugs or vaccines being tested in in vitro and in vivo models need to be moved into human clinical trials. Active preventive tactics, as well as new and upgraded diagnostics, surveillance, treatments, and vaccination strategies, need to be monitored constantly if we are to manage VBDs of medical importance.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867325666181105121146","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T12:03:36Z","timestamp":1541505816000},"page":"2974-2986","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Current Challenges in the Development of Vaccines and Drugs Against Emerging Vector-borne Diseases"],"prefix":"10.2174","volume":"26","author":[{"given":"Kwang-sun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.actatropica.2016.11.020","volume":"166","author":"Mayer S.V.","year":"2017","unstructured":"Mayer S.V.; Tesh R.B.; Vasilakis N.; The emergence of arthropod-borne viral diseases: A global prospective on dengue, chikungunya and zika fevers. Acta Trop [http:\/\/dx.doi.org\/10.1016\/j.actatropica.2016.11.020]. [PMID: 27876643].2017,166,155-163","journal-title":"Acta Trop"},{"key":"ref=2","unstructured":"A global brief on vector-borne diseases., 2014. ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.who.int\/campaigns\/world-health-day\/2014\/global-brief\/en\/\">http:\/\/www.who.int\/campaigns\/world-health-day\/2014\/global-brief\/en\/"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3376\/1081-1710(2006)31[292:AOTPFS]2.0.CO;2","volume":"31","author":"Medlock J.M.","year":"2006","unstructured":"Medlock J.M.; Avenell D.; Barrass I.; Leach S.; Analysis of the potential for survival and seasonal activity of Aedes albopictus (Diptera: Culicidae) in the United Kingdom. J Vector Ecol [http:\/\/dx.doi.org\/10.3376\/1081- 1710(2006)31[292:AOTPFS]2.0.CO;2] [PMID: 17249347] 2006,31(2),292-304","journal-title":"J Vector Ecol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","volume":"85","author":"Weaver S.C.","year":"2010","unstructured":"Weaver S.C.; Reisen W.K.; Present and future arboviral threats. Antiviral Res [http:\/\/dx.doi.org\/10.1016\/j.antiviral.2009.10.008]. [PMID: 19857523].2010,85(2),328-345","journal-title":"Antiviral Res"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1473-3099(15)70091-5","volume":"15","author":"Medlock J.M.","year":"2015","unstructured":"Medlock J.M.; Leach S.A.; Effect of climate change on vector-borne disease risk in the UK. Lancet Infect Dis [http:\/\/dx.doi.org\/10.1016\/S1473-3099(15)70091-5]. [PMID: 25808458].2015,15(6),721-730","journal-title":"Lancet Infect Dis"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.3390\/ijerph120606745","volume":"12","author":"Negev M.","year":"2015","unstructured":"Negev M.; Paz S.; Clermont A.; Pri-Or N.G.; Shalom U.; Yeger T.; Green M.S.; Impacts of climate change on vector borne diseases in the Mediterranean basin-implications for preparedness and adaptation policy. Int J Environ Res Public Health [http:\/\/dx.doi.org\/10.3390\/ijerph120606745]. [PMID: 26084000].2015,12(6),6745-6770","journal-title":"Int J Environ Res Public Health"},{"key":"ref=7","volume":"14","author":"Brand S.P.C.","year":"2017","unstructured":"Brand S.P.C.; Keeling M.J.; The impact of temperature changes on vector-borne disease transmission: Culicoides midges and bluetongue virus. J R Soc Interface [http:\/\/dx.doi.org\/10.1098\/rsif.2016.0481]. [PMID: 28298609].2017,14(128)","journal-title":"J R Soc Interface"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/nyas.13950","volume":"1436","author":"Caminade C.","year":"2019","unstructured":"Caminade C.; McIntyre K.M.; Jones A.E.; Impact of recent and future climate change on vector-borne diseases. Ann N Y Acad Sci [DOI: 10.1111\/nyas.13950. Epub 2018]. [PMID: 30120891].2019,1436(1),157-173","journal-title":"Ann N Y Acad Sci"},{"key":"ref=9","first-page":"238","volume":"10","author":"Vora N.","year":"2008","unstructured":"Vora N.; Impact of anthropogenic environmental alterations on vector-borne diseases. Medscape J Med [PMID: 19099032].2008,10(10),238","journal-title":"Medscape J Med"},{"key":"ref=10","first-page":"141","volume":"109","author":"Reiter P.","year":"2001","unstructured":"Reiter P.; Climate change and mosquito-borne disease. Environ Health Perspect [PMID: 11250812].2001,109(Suppl. 1),141-161","journal-title":"Environ Health Perspect"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00034983.1996.11813087","volume":"90","author":"Lindsay S.W.","year":"1996","unstructured":"Lindsay S.W.; Birley M.H.; Climate change and malaria transmission. Ann Trop Med Parasitol [http:\/\/dx.doi.org\/10.1080\/00034983.1996.11813087]. [PMID: 9039269].1996,90(6),573-588","journal-title":"Ann Trop Med Parasitol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.pt.2016.04.015","volume":"32","author":"Ogden N.H.","year":"2016","unstructured":"Ogden N.H.; Lindsay L.R.; Effect of climate and change on vectors and vector-borne diseases: Ticks are different. Trends Parasitol [http:\/\/dx.doi.org\/10.1016\/j.pt.2016.04.015]. [PMID: 27260548].2016,32(8),646-656","journal-title":"Trends Parasitol"},{"key":"ref=13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027987","volume":"6","author":"Carpenter S.","year":"2011","unstructured":"Carpenter S.; Wilson A.; Barber J.; Veronesi E.; Mellor P.; Venter G.; Gubbins S.; Temperature dependence of the extrinsic incubation period of orbiviruses in Culicoides biting midges. PLoS One [http:\/\/dx.doi.org\/10.1371\/journal.pone.0027987]. [PMID: 22125649].2011,6(11)","journal-title":"PLoS One"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3201\/eid0802.010198","volume":"8","author":"Schwan T.G.","year":"2002","unstructured":"Schwan T.G.; Piesman J.; Vector interactions and molecular adaptations of lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis [http:\/\/dx.doi.org\/10.3201\/eid0802.010198]. [PMID: 11897061].2002,8(2),115-121","journal-title":"Emerg Infect Dis"},{"key":"ref=15","first-page":"1136","volume":"78","author":"Githeko A.K.","year":"2000","unstructured":"Githeko A.K.; Lindsay S.W.; Confalonieri U.E.; Patz J.A.; Climate change and vector-borne diseases: a regional analysis. Bull World Health Organ [PMID: 11019462].2000,78(9),1136-1147","journal-title":"Bull World Health Organ"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3389\/fmicb.2017.02337","volume":"8","author":"Liu Z.","year":"2017","unstructured":"Liu Z.; Zhang Z.; Lai Z.; Zhou T.; Jia Z.; Gu J.; Wu K.; Chen X.G.; Temperature increase enhances Aedes albopictus competence to transmit dengue virus. Front Microbiol [http:\/\/dx.doi.org\/10.3389\/fmicb.2017.02337]. [PMID: 29250045].2017,8,2337","journal-title":"Front Microbiol"},{"key":"ref=17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006746","volume":"12","author":"Mulwa F.","year":"2018","unstructured":"Mulwa F.; Lutomiah J.; Chepkorir E.; Okello S.; Eyase F.; Tigoi C.; Kahato M.; Sang R.; Vector competence of Aedes bromeliae and Aedes vitattus mosquito populations from Kenya for chikungunya virus. PLoS Negl Trop Dis [http:\/\/dx.doi.org\/10.1371\/journal.pntd.0006746]. [PMID: 30321181].2018,12(10)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00436-015-4586-9","volume":"114","author":"Benelli G.","year":"2015","unstructured":"Benelli G.; Research in mosquito control: Current challenges for a brighter future. Parasitol Res [http:\/\/dx.doi.org\/10.1007\/s00436-015-4586-9]. [PMID: 26093499].2015,114(8),2801-2805","journal-title":"Parasitol Res"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00436-015-4656-z","volume":"114","author":"Benelli G.","year":"2015","unstructured":"Benelli G.; Plant-borne ovicides in the fight against mosquito vectors of medical and veterinary importance: a systematic review. Parasitol Res [http:\/\/dx.doi.org\/10.1007\/s00436-015-4656-z]. [PMID: 26239801].2015,114(9),3201-3212","journal-title":"Parasitol Res"},{"key":"ref=20","first-page":"002","author":"Fusco D.N.","year":"2014","unstructured":"Fusco D.N.; Chung R.T.; Review of current dengue treatment and therapeutics in development. J Bioanal Biomed 2014(S8),002","journal-title":"J Bioanal Biomed"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ecoenv.2017.01.026","volume":"139","author":"Vasantha-Srinivasan P.","year":"2017","unstructured":"Vasantha-Srinivasan P.; Senthil-Nathan S.; Ponsankar A.; Thanigaivel A.; Edwin E.S.; Selin-Rani S.; Chellappandian M.; Pradeepa V.; Lija-Escaline J.; Kalaivani K.; Hunter W.B.; Duraipandiyan V.; Al-Dhabi N.A.; Comparative analysis of mosquito (Diptera: Culicidae: Aedes aegypti Liston) responses to the insecticide Temephos and plant derived essential oil derived from Piper betle L. Ecotoxicol Environ Saf [http:\/\/dx.doi.org\/10.1016\/j.ecoenv.2017.01.026]. [PMID: 28213320].2017,139,439-446","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","volume":"366","author":"Simmons C.P.","year":"2012","unstructured":"Simmons C.P.; Farrar J.J.; Nguyen V.; Wills B.; Dengue. N Engl J Med [http:\/\/dx.doi.org\/10.1056\/NEJMra1110265]. [PMID: 22494122].2012,366(15),1423-1432","journal-title":"N Engl J Med"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.actatropica.2016.07.009","volume":"163","author":"Edwin E.S.","year":"2016","unstructured":"Edwin E.S.; Vasantha-Srinivasan P.; Senthil-Nathan S.; Thanigaivel A.; Ponsankar A.; Pradeepa V.; Selin-Rani S.; Kalaivani K.; Hunter W.B.; Abdel-Megeed A.; Duraipandiyan V.; Al-Dhabi N.A.; Anti-dengue efficacy of bioactive andrographolide from Andrographis paniculata (Lamiales: Acanthaceae) against the primary dengue vector Aedes aegypti (Diptera: Culicidae). Acta Trop [http:\/\/dx.doi.org\/10.1016\/j.actatropica.2016.07.009]. [PMID: 27443607].2016,163,167-178","journal-title":"Acta Trop"},{"key":"ref=24","volume":"11","author":"Fitzpatrick C.","year":"2017","unstructured":"Fitzpatrick C.; Haines A.; Bangert M.; Farlow A.; Hemingway J.; Velayudhan R.; An economic evaluation of vector control in the age of a dengue vaccine. PLoS Negl Trop Dis [http:\/\/dx.doi.org\/10.1371\/journal.pntd.0005785]. [PMID: 28806786].2017,11(8)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40249-016-0131-z","volume":"5","author":"Xiao J.P.","year":"2016","unstructured":"Xiao J.P.; He J.F.; Deng A.P.; Lin H.L.; Song T.; Peng Z.Q.; Wu X.C.; Liu T.; Li Z.H.; Rutherford S.; Zeng W.L.; Li X.; Ma W.J.; Zhang Y.H.; Characterizing a large outbreak of dengue fever in Guangdong Province, China. Infect Dis Poverty [http:\/\/dx.doi.org\/10.1186\/s40249-016-0131-z]. [PMID: 27142081].2016,5,44","journal-title":"Infect Dis Poverty"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2051013613507862","volume":"2","author":"Thisyakorn U.","year":"2014","unstructured":"Thisyakorn U.; Thisyakorn C.; Latest developments and future directions in dengue vaccines. Ther Adv Vaccines [http:\/\/dx.doi.org\/10.1177\/2051013613507862]. [PMID: 24757522].2014,2(1),3-9","journal-title":"Ther Adv Vaccines"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","volume":"384","author":"Capeding M.R.","year":"2014","unstructured":"Capeding M.R.; Tran N.H.; Hadinegoro S.R.; Ismail H.I.; Chotpitayasunondh T.; Chua M.N.; Luong C.Q.; Rusmil K.; Wirawan D.N.; Nallusamy R.; Pitisuttithum P.; Thisyakorn U.; Yoon I.K.; van der Vliet D.; Langevin E.; Laot T.; Hutagalung Y.; Frago C.; Boaz M.; Wartel T.A.; Tornieporth N.G.; Saville M.; Bouckenooghe A.; Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial. Lancet [http:\/\/dx.doi.org\/10.1016\/S0140-6736(14)61060-6]. [PMID: 25018116].2014,384(9951),1358-1365","journal-title":"Lancet"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"7075","DOI":"10.1016\/j.vaccine.2015.09.052","volume":"33","author":"Larsen C.P.","year":"2015","unstructured":"Larsen C.P.; Whitehead S.S.; Durbin A.P.; Dengue human infection models to advance dengue vaccine development. Vaccine [http:\/\/dx.doi.org\/10.1016\/j.vaccine.2015.09.052]. [PMID: 26424605].2015,33(50),7075-7082","journal-title":"Vaccine"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pt.2006.06.006","volume":"22","author":"Guerra C.A.","year":"2006","unstructured":"Guerra C.A.; Snow R.W.; Hay S.I.; Mapping the global extent of malaria in 2005. Trends Parasitol [http:\/\/dx.doi.org\/10.1016\/j.pt.2006.06.006]. [PMID: 16798089].2006,22(8),353-358","journal-title":"Trends Parasitol"},{"key":"ref=30","year":"2016","unstructured":"World Malaria Report 2016"},{"key":"ref=31","author":"Dhangadamajhi G.","year":"2010","unstructured":"Dhangadamajhi G.; Kar S.K.; Ranjit M.; The survival strategies of malaria parasite in the red blood cell and host cell polymorphisms. Malar Res Treat [http:\/\/dx.doi.org\/10.4061\/2010\/973094]. [PMID: 22332025].2010","journal-title":"Malar Res Treat"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00436-014-3804-1","volume":"113","author":"Isah M.B.","year":"2014","unstructured":"Isah M.B.; Ibrahim M.A.; The role of antioxidants treatment on the pathogenesis of malarial infections: A review. Parasitol Res [http:\/\/dx.doi.org\/10.1007\/s00436-014-3804-1]. [PMID: 24525759].2014,113(3),801-809","journal-title":"Parasitol Res"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"White N.J.","year":"2004","unstructured":"White N.J.; Antimalarial drug resistance. J Clin Invest [http:\/\/dx.doi.org\/10.1172\/JCI21682]. [PMID: 15085184].2004,113(8),1084-1092","journal-title":"J Clin Invest"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"Fidock D.A.","year":"2000","unstructured":"Fidock D.A.; Nomura T.; Talley A.K.; Cooper R.A.; Dzekunov S.M.; Ferdig M.T.; Ursos L.M.; Sidhu A.B.; Naud\u00e9 B.; Deitsch K.W.; Su X.Z.; Wootton J.C.; Roepe P.D.; Wellems T.E.; Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell [http:\/\/dx.doi.org\/10.1016\/S1097-2765(05)00077-8]. [PMID: 11090624].2000,6(4),861-871","journal-title":"Mol Cell"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpddr.2011.11.001","volume":"2","author":"Lehane A.M.","year":"2012","unstructured":"Lehane A.M.; McDevitt C.A.; Kirk K.; Fidock D.A.; Degrees of chloroquine resistance in Plasmodium - is the redox system involved? Int J Parasitol Drugs Drug Resist [http:\/\/dx.doi.org\/10.1016\/j.ijpddr.2011.11.001]. [PMID: 22773965].2012,2,47-57","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"Wells T.N.","year":"2015","unstructured":"Wells T.N.; Hooft van Huijsduijnen R.; Van Voorhis W.C.; Malaria medicines: a glass half full? Nat Rev Drug Discov [http:\/\/dx.doi.org\/10.1038\/nrd4573]. [PMID: 26000721].2015,14(6),424-442","journal-title":"Nat Rev Drug Discov"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-59745-204-5_18","volume":"470","author":"Cui L.","year":"2009","unstructured":"Cui L.; Trongnipatt N.; Sattabongkot J.; Udomsangpetch R.; Culture of exoerythrocytic stages of the malaria parasites Plasmodium falciparum and Plasmodium vivax. Methods Mol Biol [http:\/\/dx.doi.org\/10.1007\/978-1-59745-204-5_18]. [PMID: 19089388].2009,470,263-273","journal-title":"Methods Mol Biol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1517\/13543784.9.8.1815","volume":"9","author":"Price R.N.","year":"2000","unstructured":"Price R.N.; Artemisinin drugs: Novel antimalarial agents. Expert Opin Investig Drugs [http:\/\/dx.doi.org\/10.1517\/13543784.9.8.1815]. [PMID: 11060779].2000,9(8),1815-1827","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S1473-3099(17)30475-9","volume":"17","author":"Shanks G.D.","year":"2017","unstructured":"Shanks G.D.; M\u00f6hrle J.J.; Treating malaria: New drugs for a new era. Lancet Infect Dis [http:\/\/dx.doi.org\/10.1016\/S1473-3099(17)30475-9]. [PMID: 28916444].2017,17(12),1223-1224","journal-title":"Lancet Infect Dis"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-017-0035-3","volume":"2","author":"Coelho C.H.","year":"2017","unstructured":"Coelho C.H.; Doritchamou J.Y.A.; Zaidi I.; Duffy P.E.; Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium. NPJ Vaccines [http:\/\/dx.doi.org\/10.1038\/s41541-017-0035-3]. [PMID: 29522056].2017,2,34","journal-title":"NPJ Vaccines"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/cid\/ciu954","volume":"60","author":"Ouattara A.","year":"2015","unstructured":"Ouattara A.; Laurens M.B.; Vaccines against malaria. Clin Infect Dis [http:\/\/dx.doi.org\/10.1093\/cid\/ciu954]. [PMID: 25452593].2015,60(6),930-936","journal-title":"Clin Infect Dis"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1016\/j.vaccine.2015.07.091","volume":"33","author":"Hoffman S.L.","year":"2015","unstructured":"Hoffman S.L.; Vekemans J.; Richie T.L.; Duffy P.E.; The march toward malaria vaccines. Vaccine [http:\/\/dx.doi.org\/10.1016\/j.vaccine.2015.07.091]. [PMID: 26324116].2015,33(Suppl. 4),D13-D23","journal-title":"Vaccine"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/21645515.2015.1101197","volume":"12","author":"Schwameis M.","year":"2016","unstructured":"Schwameis M.; Buchtele N.; Wadowski P.P.; Schoergenhofer C.; Jilma B.; Chikungunya vaccines in development. Hum Vaccin Immunother [http:\/\/dx.doi.org\/10.1080\/21645515.2015.1101197]. [PMID: 26554522].2016,12(3),716-731","journal-title":"Hum Vaccin Immunother"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00431-009-0986-0","volume":"169","author":"Robin S.","year":"2010","unstructured":"Robin S.; Ramful D.; Zettor J.; Benhamou L.; Jaffar-Bandjee M.C.; Rivi\u00e8re J.P.; Marichy J.; Ezzedine K.; Alessandri J.L.; Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur J Pediatr [http:\/\/dx.doi.org\/10.1007\/s00431-009-0986-0]. [PMID: 19401826].2010,169(1),67-72","journal-title":"Eur J Pediatr"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrmicro2368","volume":"8","author":"Schwartz O.","year":"2010","unstructured":"Schwartz O.; Albert M.L.; Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol [http:\/\/dx.doi.org\/10.1038\/nrmicro2368]. [PMID: 20551973].2010,8(7),491-500","journal-title":"Nat Rev Microbiol"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/589925","volume":"47","author":"Bordi L.","year":"2008","unstructured":"Bordi L.; Carletti F.; Castilletti C.; Chiappini R.; Sambri V.; Cavrini F.; Ippolito G.; Di Caro A.; Capobianchi M.R.; Presence of the A226V mutation in autochthonous and imported Italian chikungunya virus strains. Clin Infect Dis [http:\/\/dx.doi.org\/10.1086\/589925]. [PMID: 18605910].2008,47(3),428-429","journal-title":"Clin Infect Dis"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/vbz.2009.0005","volume":"10","author":"Paupy C.","year":"2010","unstructured":"Paupy C.; Ollomo B.; Kamgang B.; Moutailler S.; Rousset D.; Demanou M.; Herv\u00e9 J.P.; Leroy E.; Simard F.; Comparative role of Aedes albopictus and Aedes aegypti in the emergence of Dengue and Chikungunya in central Africa. Vector Borne Zoonotic Dis [http:\/\/dx.doi.org\/10.1089\/vbz.2009.0005]. [PMID: 19725769].2010,10(3),259-266","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref=48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001168","volume":"2","author":"Vazeille M.","year":"2007","unstructured":"Vazeille M.; Moutailler S.; Coudrier D.; Rousseaux C.; Khun H.; Huerre M.; Thiria J.; Dehecq J.S.; Fontenille D.; Schuffenecker I.; Despres P.; Failloux A.B.; Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One [http:\/\/dx.doi.org\/10.1371\/journal.pone.0001168]. [PMID: 18000540].2007,2(11)","journal-title":"PLoS One"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/517537","volume":"44","author":"Borgherini G.","year":"2007","unstructured":"Borgherini G.; Poubeau P.; Staikowsky F.; Lory M.; Le Moullec N.; Becquart J.P.; Wengling C.; Michault A.; Paganin F.; Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis [http:\/\/dx.doi.org\/10.1086\/517537]. [PMID: 17479933].2007,44(11),1401-1407","journal-title":"Clin Infect Dis"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1590\/S0074-02762011000800003","volume":"106","author":"Kumar N.P.","year":"2011","unstructured":"Kumar N.P.; Suresh A.; Vanamail P.; Sabesan S.; Krishnamoorthy K.G.; Mathew J.; Jose V.T.; Jambulingam P.; Chikungunya virus outbreak in Kerala, India, 2007: a seroprevalence study. Mem Inst Oswaldo Cruz [http:\/\/dx.doi.org\/10.1590\/S0074-02762011000800003]. [PMID: 22241110].2011,106(8),912-916","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1743-422X-10-174","volume":"10","author":"Wu D.","year":"2013","unstructured":"Wu D.; Zhang Y.; Zhouhui Q.; Kou J.; Liang W.; Zhang H.; Monagin C.; Zhang Q.; Li W.; Zhong H.; He J.; Li H.; Cai S.; Ke C.; Lin J.; Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010, Guangdong, China. Virol J [http:\/\/dx.doi.org\/10.1186\/1743-422X-10-174]. [PMID: 23725047].2013,10,174","journal-title":"Virol J"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1001\/jama.297.20.2278","volume":"297","author":"Chretien J.P.","year":"2007","unstructured":"Chretien J.P.; Fukuda M.; Noedl H.; Improving surveillance for antimalarial drug resistance. JAMA [http:\/\/dx.doi.org\/10.1001\/jama.297.20.2278]. [PMID: 17522014].2007,297(20),2278-2281","journal-title":"JAMA"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4103\/0255-0857.71812","volume":"28","author":"Srikanth P.","year":"2010","unstructured":"Srikanth P.; Sarangan G.; Mallilankaraman K.; Nayar S.A.; Barani R.; Mattew T.; Selvaraj G.F.; Sheriff K.A.; Palani G.; Muthumani K.; Molecular characterization of Chikungunya virus during an outbreak in South India. Indian J Med Microbiol [http:\/\/dx.doi.org\/10.4103\/0255-0857.71812]. [PMID: 20966558].2010,28(4),299-302","journal-title":"Indian J Med Microbiol"},{"key":"ref=54","first-page":"1374","volume":"41","author":"Apandi Y.","year":"2010","unstructured":"Apandi Y.; Lau S.K.; Izmawati N.; Amal N.M.; Faudzi Y.; Mansor W.; Hani M.H.; Zainah S.; Identification of Chikungunya virus strains circulating in Kelantan, Malaysia in 2009. Southeast Asian J Trop Med Public Health [PMID: 21329313].2010,41(6),1374-1380","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.ijid.2010.01.001","volume":"14","author":"Rianthavorn P.","year":"2010","unstructured":"Rianthavorn P.; Prianantathavorn K.; Wuttirattanakowit N.; Theamboonlers A.; Poovorawan Y.; An outbreak of chikungunya in southern Thailand from 2008 to 2009 caused by African strains with A226V mutation. Int J Infect Dis [http:\/\/dx.doi.org\/10.1016\/j.ijid.2010.01.001]. [PMID: 20417142].2010,14(Suppl. 3),e161-e165","journal-title":"Int J Infect Dis"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3201\/eid2008.140268","volume":"20","author":"Lanciotti R.S.","year":"2014","unstructured":"Lanciotti R.S.; Valadere A.M.; Transcontinental movement of Asian genotype chikungunya virus. Emerg Infect Dis [http:\/\/dx.doi.org\/10.3201\/eid2008.140268]. [PMID: 25076384].2014,20(8),1400-1402","journal-title":"Emerg Infect Dis"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(14)60185-9","volume":"383","author":"Leparc-Goffart I.","year":"2014","unstructured":"Leparc-Goffart I.; Nougairede A.; Cassadou S.; Prat C.; de Lamballerie X.; Chikungunya in the Americas. Lancet [http:\/\/dx.doi.org\/10.1016\/S0140-6736(14)60185-9]. [PMID: 24506907].2014,383(9916),514","journal-title":"Lancet"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1086\/605496","volume":"49","author":"Staples J.E.","year":"2009","unstructured":"Staples J.E.; Breiman R.F.; Powers A.M.; Chikungunya fever: An epidemiological review of a re-emerging infectious disease. Clin Infect Dis [http:\/\/dx.doi.org\/10.1086\/605496]. [PMID: 19663604].2009,49(6),942-948","journal-title":"Clin Infect Dis"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","volume":"82","author":"Khan M.","year":"2010","unstructured":"Khan M.; Santhosh S.R.; Tiwari M.; Lakshmana Rao P.V.; Parida M.; Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol [http:\/\/dx.doi.org\/10.1002\/jmv.21663]. [PMID: 20336760].2010,82(5),817-824","journal-title":"J Med Virol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3855\/T2.2.140","volume":"2","author":"Ravichandran R.","year":"2008","unstructured":"Ravichandran R.; Manian M.; Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries [http:\/\/dx.doi.org\/10.3855\/T2.2.140]. [PMID: 19738340].2008,2(2),140-142","journal-title":"J Infect Dev Ctries"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.drudis.2013.05.002","volume":"18","author":"Kaur P.","year":"2013","unstructured":"Kaur P.; Chu J.J.; Chu H.; Chikungunya virus: An update on antiviral development and challenges. Drug Discov Today [http:\/\/dx.doi.org\/10.1016\/j.drudis.2013.05.002]. [PMID: 23684571].2013,18(19-20),969-983","journal-title":"Drug Discov Today"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1743-422X-5-33","volume":"5","author":"de Lamballerie X.","year":"2008","unstructured":"de Lamballerie X.; Leroy E.; Charrel R.N.; Ttsetsarkin K.; Higgs S.; Gould E.A.; Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virol J [http:\/\/dx.doi.org\/10.1186\/1743-422X-5-33]. [PMID: 18304328].2008,5,33","journal-title":"Virol J"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13062-015-0050-0","volume":"10","author":"Ahola T.","year":"2015","unstructured":"Ahola T.; Karlin D.G.; Sequence analysis reveals a conserved extension in the capping enzyme of the alphavirus supergroup, and a homologous domain in nodaviruses. Biol Direct [http:\/\/dx.doi.org\/10.1186\/s13062-015-0050-0]. [PMID: 25886938].2015,10,16","journal-title":"Biol Direct"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"31819","DOI":"10.1038\/srep31819","volume":"6","author":"Delang L.","year":"2016","unstructured":"Delang L.; Li C.; Tas A.; Qu\u00e9rat G.; Albulescu I.C.; De Burghgraeve T.; Guerrero N.A.; Gigante A.; Piorkowski G.; Decroly E.; Jochmans D.; Canard B.; Snijder E.J.; P\u00e9rez-P\u00e9rez M.J.; van Hemert M.J.; Coutard B.; Leyssen P.; Neyts J.; The viral capping enzyme nsP1: A novel target for the inhibition of chikungunya virus infection. Sci Rep [http:\/\/dx.doi.org\/10.1038\/srep31819]. [PMID: 27545976].2016,6,31819","journal-title":"Sci Rep"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2013.05.086","volume":"31","author":"Brandler S.","year":"2013","unstructured":"Brandler S.; Ruffi\u00e9 C.; Combredet C.; Brault J.B.; Najburg V.; Prevost M.C.; Habel A.; Tauber E.; Despr\u00e8s P.; Tangy F.; A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus. Vaccine [http:\/\/dx.doi.org\/10.1016\/j.vaccine.2013.05.086]. [PMID: 23742993].2013,31(36),3718-3725","journal-title":"Vaccine"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","volume":"15","author":"Ramsauer K.","year":"2015","unstructured":"Ramsauer K.; Schwameis M.; Firbas C.; M\u00fcllner M.; Putnak R.J.; Thomas S.J.; Despr\u00e8s P.; Tauber E.; Jilma B.; Tangy F.; Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect Dis [http:\/\/dx.doi.org\/10.1016\/S1473-3099(15)70043-5]. [PMID: 25739878].2015,15(5),519-527","journal-title":"Lancet Infect Dis"},{"key":"ref=67","year":"2013","unstructured":"ClinicalTrialsgov 2013","journal-title":"ClinicalTrialsgov"},{"key":"ref=68","unstructured":"Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine (MV-CHIK-202)., https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02861586"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1016\/j.vaccine.2013.09.045","volume":"31","author":"Metz S.W.","year":"2013","unstructured":"Metz S.W.; Martina B.E.; van den Doel P.; Geertsema C.; Osterhaus A.D.; Vlak J.M.; Pijlman G.P.; Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits. Vaccine [http:\/\/dx.doi.org\/10.1016\/j.vaccine.2013.09.045]. [PMID: 24099875].2013,31(51),6092-6096","journal-title":"Vaccine"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nm.2105","volume":"16","author":"Akahata W.","year":"2010","unstructured":"Akahata W.; Yang Z.Y.; Andersen H.; Sun S.; Holdaway H.A.; Kong W.P.; Lewis M.G.; Higgs S.; Rossmann M.G.; Rao S.; Nabel G.J.; A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med [http:\/\/dx.doi.org\/10.1038\/nm.2105]. [PMID: 20111039].2010,16(3),334-338","journal-title":"Nat Med"},{"key":"ref=71","volume":"7","author":"Metz S.W.","year":"2013","unstructured":"Metz S.W.; Gardner J.; Geertsema C.; Le T.T.; Goh L.; Vlak J.M.; Suhrbier A.; Pijlman G.P.; Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl Trop Dis [http:\/\/dx.doi.org\/10.1371\/journal.pntd.0002124]. [PMID: 23516657].2013,7(3)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=72","unstructured":"Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02562482"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/14760584.2016.1192474","volume":"15","author":"Tripp R.A.","year":"2016","unstructured":"Tripp R.A.; Ross T.M.; Development of a Zika vaccine. Expert Rev Vaccines [http:\/\/dx.doi.org\/10.1080\/14760584.2016.1192474]. [PMID: 27212079].2016,15(9),1083-1085","journal-title":"Expert Rev Vaccines"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S2055-6640(20)30330-7","volume":"3","author":"Lagunas-Rangel F.A.","year":"2017","unstructured":"Lagunas-Rangel F.A.; Viveros-Sandoval M.E.; Reyes-Sandoval A.; Current trends in Zika vaccine development. J Virus Erad [PMID: 28758019].2017,3(3),124-127","journal-title":"J Virus Erad"},{"key":"ref=75","unstructured":"Zika and Pregnancy. https:\/\/www.cdc.gov\/pregnancy\/ zika\/data\/pregnancy-outcomes.html"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coviro.2017.03.006","volume":"23","author":"Fernandez E.","year":"2017","unstructured":"Fernandez E.; Diamond M.S.; Vaccination strategies against Zika virus. Curr Opin Virol [http:\/\/dx.doi.org\/10.1016\/j.coviro.2017.03.006]. [PMID: 28432975].2017,23,59-67","journal-title":"Curr Opin Virol"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.chom.2016.04.006","volume":"19","author":"Wang L.","year":"2016","unstructured":"Wang L.; Valderramos S.G.; Wu A.; Ouyang S.; Li C.; Brasil P.; Bonaldo M.; Coates T.; Nielsen-Saines K.; Jiang T.; Aliyari R.; Cheng G.; From mosquitos to humans: Genetic evolution of zika virus. Cell Host Microbe [http:\/\/dx.doi.org\/10.1016\/j.chom.2016.04.006]. [PMID: 27091703].2016,19(5),561-565","journal-title":"Cell Host Microbe"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41579-018-0039-7","volume":"16","author":"Abbink P.","year":"2018","unstructured":"Abbink P.; Stephenson K.E.; Barouch D.H.; Zika virus vaccines. Nat Rev Microbiol [http:\/\/dx.doi.org\/10.1038\/s41579-018-0039-7]. [PMID: 29921914].2018,16(10),594-600","journal-title":"Nat Rev Microbiol"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coviro.2017.03.006","volume":"23","author":"Fernandez E.","year":"2017","unstructured":"Fernandez E.; Diamond M.S.; Vaccination strategies against Zika virus. Curr Opin Virol [http:\/\/dx.doi.org\/10.1016\/j.coviro.2017.03.006]. [PMID: 28432975].2017,23,59-67","journal-title":"Curr Opin Virol"},{"key":"ref=80","unstructured":"Zika Virus Vaccines, https:\/\/www.niaid.nih.gov\/diseases-conditions\/zika-vaccines"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12916-018-1067-x","volume":"16","author":"Wilder-Smith A.","year":"2018","unstructured":"Wilder-Smith A.; Vannice K.; Durbin A.; Hombach J.; Thomas S.J.; Thevarjan I.; Simmons C.P.; Zika vaccines and therapeutics: Landscape analysis and challenges ahead. BMC Med [http:\/\/dx.doi.org\/10.1186\/s12916-018-1067-x]. [PMID: 29871628].2018,16(1),84","journal-title":"BMC Med"},{"key":"ref=82","unstructured":""},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","volume":"354","author":"Dowd K.A.","year":"2016","unstructured":"Dowd K.A.; Ko S.Y.; Morabito K.M.; Yang E.S.; Pelc R.S.; DeMaso C.R.; Castilho L.R.; Abbink P.; Boyd M.; Nityanandam R.; Gordon D.N.; Gallagher J.R.; Chen X.; Todd J.P.; Tsybovsky Y.; Harris A.; Huang Y.S.; Higgs S.; Vanlandingham D.L.; Andersen H.; Lewis M.G.; De La Barrera R.; Eckels K.H.; Jarman R.G.; Nason M.C.; Barouch D.H.; Roederer M.; Kong W.P.; Mascola J.R.; Pierson T.C.; Graham B.S.; Rapid development of a DNA vaccine for Zika virus. Science [http:\/\/dx.doi.org\/10.1126\/science.aai9137]. [PMID: 27708058].2016,354(6309),237-240","journal-title":"Science"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.4161\/hv.24702","volume":"9","author":"Diehl M.C.","year":"2013","unstructured":"Diehl M.C.; Lee J.C.; Daniels S.E.; Tebas P.; Khan A.S.; Giffear M.; Sardesai N.Y.; Bagarazzi M.L.; Tolerability of intramuscular and intradermal delivery by CELLECTRA() adaptive constant current electroporation device in healthy volunteers. Hum Vaccin Immunother [http:\/\/dx.doi.org\/10.4161\/hv.24702]. [PMID: 24051434].2013,9(10),2246-2252","journal-title":"Hum Vaccin Immunother"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"Abbink P.","year":"2016","unstructured":"Abbink P.; Larocca R.A.; De La Barrera R.A.; Bricault C.A.; Moseley E.T.; Boyd M.; Kirilova M.; Li Z.; Ng\u2019ang\u2019a D.; Nanayakkara O.; Nityanandam R.; Mercado N.B.; Borducchi E.N.; Agarwal A.; Brinkman A.L.; Cabral C.; Chandrashekar A.; Giglio P.B.; Jetton D.; Jimenez J.; Lee B.C.; Mojta S.; Molloy K.; Shetty M.; Neubauer G.H.; Stephenson K.E.; Peron J.P.S.; Zanotto P.M.D.; Misamore J.; Finneyfrock B.; Lewis M.G.; Alter G.; Modjarrad K.; Jarman R.G.; Eckels K.H.; Michael N.L.; Thomas S.J.; Barouch D.H.; Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science [http:\/\/dx.doi.org\/10.1126\/science.aah6157]. [PMID: 27492477].2016,353(6304),1129-1132","journal-title":"Science"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","volume":"543","author":"Pardi N.","year":"2017","unstructured":"Pardi N.; Hogan M.J.; Pelc R.S.; Muramatsu H.; Andersen H.; DeMaso C.R.; Dowd K.A.; Sutherland L.L.; Scearce R.M.; Parks R.; Wagner W.; Granados A.; Greenhouse J.; Walker M.; Willis E.; Yu J.S.; McGee C.E.; Sempowski G.D.; Mui B.L.; Tam Y.K.; Huang Y.J.; Vanlandingham D.; Holmes V.M.; Balachandran H.; Sahu S.; Lifton M.; Higgs S.; Hensley S.E.; Madden T.D.; Hope M.J.; Karik\u00f3 K.; Santra S.; Graham B.S.; Lewis M.G.; Pierson T.C.; Haynes B.F.; Weissman D.; Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature [http:\/\/dx.doi.org\/10.1038\/nature21428]. [PMID: 28151488].2017,543(7644),248-251","journal-title":"Nature"},{"key":"ref=87","unstructured":""},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coviro.2017.03.006","volume":"23","author":"Fernandez E.","year":"2017","unstructured":"Fernandez E.; Diamond M.S.; Vaccination strategies against Zika virus. Curr Opin Virol [http:\/\/dx.doi.org\/10.1016\/j.coviro.2017.03.006]. [PMID: 28432975].2017,23,59-67","journal-title":"Curr Opin Virol"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3201\/eid2304.161879","volume":"23","author":"Halstead S.B.","year":"2017","unstructured":"Halstead S.B.; Biologic evidence required for Zika disease enhancement by Dengue antibodies. Emerg Infect Dis [http:\/\/dx.doi.org\/10.3201\/eid2304.161879]. [PMID: 28322690].2017,23(4),569-573","journal-title":"Emerg Infect Dis"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1590\/0037-8682-0014-2012","volume":"46","author":"Domingos A.","year":"2013","unstructured":"Domingos A.; Antunes S.; Borges L.; Ros\u00e1rio V.E.; Approaches towards tick and tick-borne diseases control. Rev Soc Bras Med Trop [http:\/\/dx.doi.org\/10.1590\/0037-8682-0014-2012]. [PMID: 23559344].2013,46(3),265-269","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.pt.2012.07.003","volume":"28","author":"Dantas-Torres F.","year":"2012","unstructured":"Dantas-Torres F.; Chomel B.B.; Otranto D.; Ticks and tick-borne diseases: A One Health perspective. Trends Parasitol [http:\/\/dx.doi.org\/10.1016\/j.pt.2012.07.003]. [PMID: 22902521].2012,28(10),437-446","journal-title":"Trends Parasitol"},{"key":"ref=92","author":"Martins J.R.","year":"1995","unstructured":"Martins J.R.; Corr\u00eaa B.L.; Ceres\u00e9r V.H.; Arteche C.C.P.; 1995"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00436-012-3023-6","volume":"111","author":"Tavassoli M.","year":"2012","unstructured":"Tavassoli M.; Malekifard F.; Soleimanzadeh A.; Pourseyed S.H.; Bernousi I.; Mardani K.; Susceptibility of different life stages of Ornithodoros lahorensis to entomopathogenic fungi Metarhizium anisopliae and Beauveria bassiana. Parasitol Res [http:\/\/dx.doi.org\/10.1007\/s00436-012-3023-6]. [PMID: 22782474].2012,111(4),1779-1783","journal-title":"Parasitol Res"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14760584.2016.1111142","volume":"15","author":"\u0160mit R.","year":"2016","unstructured":"\u0160mit R.; Postma M.J.; Vaccines for tick-borne diseases and cost-effectiveness of vaccination: A public health challenge to reduce the diseases\u2019 burden. Expert Rev Vaccines [http:\/\/dx.doi.org\/10.1586\/14760584.2016.1111142]. [PMID: 26559456].2016,15(1),5-7","journal-title":"Expert Rev Vaccines"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.4.5.747","volume":"4","author":"Zent O.","year":"2005","unstructured":"Zent O.; Br\u00f6ker M.; Tick-borne encephalitis vaccines: Past and present. Expert Rev Vaccines [http:\/\/dx.doi.org\/10.1586\/14760584.4.5.747]. [PMID: 16221075].2005,4(5),747-755","journal-title":"Expert Rev Vaccines"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S1473-3099(13)70110-5","volume":"13","author":"Wressnigg N.","year":"2013","unstructured":"Wressnigg N.; P\u00f6llabauer E.M.; Aichinger G.; Portsmouth D.; L\u00f6w-Baselli A.; Fritsch S.; Livey I.; Crowe B.A.; Schwendinger M.; Br\u00fchl P.; Pilz A.; Dvorak T.; Singer J.; Firth C.; Luft B.; Schmitt B.; Zeitlinger M.; M\u00fcller M.; Kollaritsch H.; Paulke-Korinek M.; Esen M.; Kremsner P.G.; Ehrlich H.J.; Barrett P.N.; Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: A double-blind, randomised, dose-escalation phase 1\/2 trial. Lancet Infect Dis [http:\/\/dx.doi.org\/10.1016\/S1473-3099(13)70110-5]. [PMID: 23665341].2013,13(8),680-689","journal-title":"Lancet Infect Dis"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fcimb.2012.00170","volume":"2","author":"Valbuena G.","year":"2013","unstructured":"Valbuena G.; Walker D.H.; Approaches to vaccines against Orientia tsutsugamushi. Front Cell Infect Microbiol [http:\/\/dx.doi.org\/10.3389\/fcimb.2012.00170]. [PMID: 23316486].2013,2,170","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1148\/rg.271065074","volume":"27","author":"Jeong Y.J.","year":"2007","unstructured":"Jeong Y.J.; Kim S.; Wook Y.D.; Lee J.W.; Kim K.I.; Lee S.H.; Scrub typhus: clinical, pathologic, and imaging findings. Radiographics [http:\/\/dx.doi.org\/10.1148\/rg.271065074]. [PMID: 17235005].2007,27(1),161-172","journal-title":"Radiographics"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5492\/wjccm.v4.i3.244","volume":"4","author":"Peter J.V.","year":"2015","unstructured":"Peter J.V.; Sudarsan T.I.; Prakash J.A.J.; Varghese G.M.; Severe scrub typhus infection: Clinical features, diagnostic challenges and management. World J Crit Care Med [http:\/\/dx.doi.org\/10.5492\/wjccm.v4.i3.244]. [PMID: 26261776].2015,4(3),244-250","journal-title":"World J Crit Care Med"},{"key":"ref=100","volume":"11","author":"Xu G.","year":"2017","unstructured":"Xu G.; Walker D.H.; Jupiter D.; Melby P.C.; Arcari C.M.; A review of the global epidemiology of scrub typhus. PLoS Negl Trop Dis 2017,11(11)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/ijd.IJD_388_17","volume":"62","author":"Chakraborty S.","year":"2017","unstructured":"Chakraborty S.; Sarma N.; Scrub typhus: An emerging threat. Indian J Dermatol [PMID: 28979009].2017,62(5),478-485","journal-title":"Indian J Dermatol"},{"key":"ref=102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005838","volume":"11","author":"Bonell A.","year":"2017","unstructured":"Bonell A.; Lubell Y.; Newton P.N.; Crump J.A.; Paris D.H.; Estimating the burden of scrub typhus: A systematic review. PLoS Negl Trop Dis [http:\/\/dx.doi.org\/10.1371\/journal.pntd.0005838]. [PMID: 28945755].2017,11(9)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1086\/596576","volume":"48","author":"Kelly D.J.","year":"2009","unstructured":"Kelly D.J.; Fuerst P.A.; Ching W.M.; Richards A.L.; Scrub typhus: the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi. Clin Infect Dis [http:\/\/dx.doi.org\/10.1086\/596576]. [PMID: 19220144].2009,48(Suppl. 3),S203-S230","journal-title":"Clin Infect Dis"},{"key":"ref=104","volume":"9","author":"Ha N.Y.","year":"2015","unstructured":"Ha N.Y.; Sharma P.; Kim G.; Kim Y.; Min C.K.; Choi M.S.; Kim I.S.; Cho N.H.; Immunization with an autotransporter protein of Orientia tsutsugamushi provides protective immunity against scrub typhus. PLoS Negl Trop Dis [http:\/\/dx.doi.org\/10.1371\/journal.pntd.0003585]. [PMID: 25768004].2015,9(3)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=105","volume":"12","author":"Lee M.J.","year":"2017","unstructured":"Lee M.J.; Hung S.H.; Huang M.C.; Tsai T.; Chen C.T.; Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells. PLoS One [http:\/\/dx.doi.org\/10.1371\/journal.pone.0178493]. [PMID: 28558025].2017,12(5)","journal-title":"PLoS One"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2169\/internalmedicine.51.7816","volume":"51","author":"Fang Y.","year":"2012","unstructured":"Fang Y.; Huang Z.; Tu C.; Zhang L.; Ye D.; Zhu B.P.; Meta-analysis of drug treatment for scrub typhus in Asia. Intern Med [http:\/\/dx.doi.org\/10.2169\/internalmedicine.51.7816]. [PMID: 22975540].2012,51(17),2313-2320","journal-title":"Intern Med"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/td.2010.100311","volume":"41","author":"Rajapakse S.","year":"2011","unstructured":"Rajapakse S.; Rodrigo C.; Fernando S.D.; Drug treatment of scrub typhus. Trop Doct [http:\/\/dx.doi.org\/10.1258\/td.2010.100311]. [PMID: 21172901].2011,41(1),1-4","journal-title":"Trop Doct"},{"key":"ref=108","unstructured":""},{"key":"ref=109","unstructured":""},{"key":"ref=110","unstructured":"New Vaccines for a Safer World. Our Challenge ext-link-type=\"uri\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/cepi.net\/mission#Our-challenge\">http:\/\/cepi.net\/mission#Our-challenge"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/167030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T03:45:34Z","timestamp":1720755934000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/167030\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":110,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,8,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666181105121146","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}